Cabergoline

GPTKB entity

Statements (35)
Predicate Object
gptkbp:instanceOf gptkb:drug
ergoline derivative
gptkbp:approvalYear 1996
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode G02CB03
gptkbp:brand Cabaser
Dostinex
gptkbp:CASNumber 81409-90-7
gptkbp:chemicalClass alkaloid
gptkbp:contraindication uncontrolled hypertension
history of cardiac valvulopathy
gptkbp:developedBy Farmitalia-Carlo Erba
gptkbp:eliminationHalfLife 63-69 hours
gptkbp:excretion urine
bile
gptkbp:hasMolecularFormula C26H37N5O2
https://www.w3.org/2000/01/rdf-schema#label Cabergoline
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction dopamine agonist
gptkbp:metabolism liver
gptkbp:pregnancyCategory B (US)
gptkbp:proteinBinding 41-42%
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
constipation
dizziness
fatigue
headache
hypotension
gptkbp:synonym 1-[(6-allylergolin-8β-yl)-carbonyl]-1-(3-dimethylaminopropyl)-3-ethylurea
gptkbp:usedFor gptkb:hyperprolactinemia
gptkb:Parkinson's_disease
prolactinomas
gptkbp:bfsParent gptkb:N04BB
gptkbp:bfsLayer 8